Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,827.44
(
0.66%
)
US TECH 100
24,394.40
(
0.62%
)
Dow Jones
48,237.44
(
0.68%
)
Brent Oil
95.17
(
0.35%
)
Bitcoin
72,076.02
(
1.33%
)
News Focus
News Focus
Post# of 820906
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

flipper44

Send PM Follow Ignore
Followers 307
Posts 37239
Boards Moderated 1
Alias Born 11/14/2013

flipper44

Member Level

Re: FeMike post# 448290

Thursday, 03/03/2022 1:51:56 PM

Thursday, March 03, 2022 1:51:56 PM

Post# of 820906
This issue is such small potatoes (from a financial perspective) compared to Flaskwork’s highly probable certification, if DCVax-l is also approved. If you really look at what Ex is indirectly saying, it fits into the likelihood that non-flaskworks commercial production of DCVax is not likely in the cards in the medium to long term. That’s probably a very good thing. In other words, Flaskworks is (likely) the future.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News